Search Results - Alika, Alex

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 1137: Determination of a recommended Phase 2 dose (RP2D) for SRF388, a first-in-class IL-27-blocking antibody, in patients with advanced solid tumors

    Abstract 1137: Determination of a recommended Phase 2 dose (RP2D) for SRF388, a first-in-class IL-27-blocking antibody, in patients with advanced solid tumors by Hill, Jonathan A., White, Kerry F., Rausch, Matthew, Chung, Jou-Ku, Patnaik, Amita, Naing, Aung, Morgensztern, Daniel, Mantia, Charlene M., Tannir, Nizar M., Smith, Lon S., Bowers, Beth, Alika, Alex, Harshman, Lauren C., Lee, Benjamin H.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract PD18-09: ACE-Breast-03: Efficacy and safety of ARX788 in patients with HER2+ metastatic breast cancer previously treated with T-DM1

    Abstract PD18-09: ACE-Breast-03: Efficacy and safety of ARX788 in patients with HER2+ metastatic breast cancer previously treated with T-DM1 by Hurvitz, Sara, Kalinsky, Kevin, Ganju, Vinod, Ali, Kashif, Agrawal, Laila, Gradishar, William, Sledge, George, Thummala, Anu, Chan, Arlene, Frentzas, Sophia, Sohn, Joo Hyuk, Park, Kyong-Hwa, Park, Keon Uk, Shannon, Catherine, Drago, Joshua, Tolaney, Sara, Rugo, Hope, Press, Michael F., Alika, Alex, Xu, Dong, Lu, Janice, Tripathy, Debu

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: